Background/aim. Endogenous cannabinoids (ECs) include anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Recently, novel EC-related molecules have been discovered, i.e. oleoyl-ethanolamine (OEA) and palmitoyl-ethanolamine (PEA). AEA has been implicated in the pathogenesis of cardiovascular alterations in experimental cirrhosis, but the data in humans are sporadic and limited to AEA. Thus, we assessed whether: (1) the EC system is up-regulated in cirrhosis by comparing plasma and liver EC levels in cirrhotic pts and controls; (2) the cirrhotic liver contributes to the circulating EC by measuring their concentrations in brachial and hepatic veins; and (3) the EC levels correlate with systemic hemodynamics, portal pressure, liver and renal functions.

Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis / Caraceni P, Domenicali M, Viola A, Piscitelli F, Petrosino S, Giannone F, Berzigotti A, Cescon M, Grazi G.L, Golfieri R, Zoli M, Di Marzo V, Bernardi M.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - ELETTRONICO. - 41:3(2009), pp. 14-14. [10.1016/j.dld.2008.12.031]

Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis

Caraceni P;Domenicali M
;
Giannone F;Berzigotti A;Cescon M;Golfieri R;Zoli M;Bernardi M.
2009

Abstract

Background/aim. Endogenous cannabinoids (ECs) include anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Recently, novel EC-related molecules have been discovered, i.e. oleoyl-ethanolamine (OEA) and palmitoyl-ethanolamine (PEA). AEA has been implicated in the pathogenesis of cardiovascular alterations in experimental cirrhosis, but the data in humans are sporadic and limited to AEA. Thus, we assessed whether: (1) the EC system is up-regulated in cirrhosis by comparing plasma and liver EC levels in cirrhotic pts and controls; (2) the cirrhotic liver contributes to the circulating EC by measuring their concentrations in brachial and hepatic veins; and (3) the EC levels correlate with systemic hemodynamics, portal pressure, liver and renal functions.
2009
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis / Caraceni P, Domenicali M, Viola A, Piscitelli F, Petrosino S, Giannone F, Berzigotti A, Cescon M, Grazi G.L, Golfieri R, Zoli M, Di Marzo V, Bernardi M.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - ELETTRONICO. - 41:3(2009), pp. 14-14. [10.1016/j.dld.2008.12.031]
Caraceni P, Domenicali M, Viola A, Piscitelli F, Petrosino S, Giannone F, Berzigotti A, Cescon M, Grazi G.L, Golfieri R, Zoli M, Di Marzo V, Bernardi M.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/665553
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact